|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Campylobacter Infections | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Infection | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Gram-Negative Bacterial Infections | |||||
| 4 | Sponsors listed in this trial | ||||
| University of Vermont | |||||
| Naval Medical Research Center | |||||
| ACE BioSciences A/S | |||||